GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » Cyclically Adjusted Revenue per Share

3B BlackBio Dx (BOM:532067) Cyclically Adjusted Revenue per Share : ₹95.04 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

3B BlackBio Dx's adjusted revenue per share for the three months ended in Mar. 2024 was ₹26.609. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹95.04 for the trailing ten years ended in Mar. 2024.

During the past 12 months, 3B BlackBio Dx's average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of 3B BlackBio Dx was 9.50% per year. The lowest was 9.50% per year. And the median was 9.50% per year.

As of today (2024-06-06), 3B BlackBio Dx's current stock price is ₹852.05. 3B BlackBio Dx's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹95.04. 3B BlackBio Dx's Cyclically Adjusted PS Ratio of today is 8.97.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of 3B BlackBio Dx was 10.27. The lowest was 3.71. And the median was 5.49.


3B BlackBio Dx Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for 3B BlackBio Dx's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx Cyclically Adjusted Revenue per Share Chart

3B BlackBio Dx Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 72.42 80.71 88.01 95.04

3B BlackBio Dx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.01 91.17 91.66 93.18 95.04

Competitive Comparison of 3B BlackBio Dx's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, 3B BlackBio Dx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's Cyclically Adjusted PS Ratio falls into.



3B BlackBio Dx Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, 3B BlackBio Dx's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=26.609/153.0345*153.0345
=26.609

Current CPI (Mar. 2024) = 153.0345.

3B BlackBio Dx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.255 94.103 6.920
201409 10.165 96.780 16.073
201412 4.830 96.780 7.637
201503 9.897 97.163 15.588
201506 4.334 99.841 6.643
201509 8.606 101.753 12.943
201512 7.796 102.901 11.594
201603 7.019 102.518 10.478
201606 3.933 105.961 5.680
201609 9.534 105.961 13.769
201612 6.754 105.196 9.825
201703 5.054 105.196 7.352
201706 6.549 107.109 9.357
201709 12.278 109.021 17.235
201712 9.198 109.404 12.866
201803 8.996 109.786 12.540
201806 6.739 111.317 9.265
201809 10.940 115.142 14.540
201812 7.276 115.142 9.670
201903 8.477 118.202 10.975
201906 7.497 120.880 9.491
201909 12.834 123.175 15.945
201912 9.149 126.235 11.091
202003 8.978 124.705 11.018
202006 70.445 127.000 84.886
202009 170.554 130.118 200.592
202012 56.865 130.889 66.486
202103 25.149 131.771 29.207
202106 43.511 134.084 49.660
202109 23.191 135.847 26.125
202112 19.125 138.161 21.184
202203 24.506 138.822 27.015
202206 18.139 142.347 19.501
202209 19.960 144.661 21.115
202212 19.698 145.763 20.681
202303 23.701 146.865 24.697
202306 21.768 150.280 22.167
202309 21.631 151.492 21.851
202312 20.131 152.924 20.146
202403 26.609 153.035 26.609

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


3B BlackBio Dx  (BOM:532067) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

3B BlackBio Dx's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=852.05/95.04
=8.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of 3B BlackBio Dx was 10.27. The lowest was 3.71. And the median was 5.49.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


3B BlackBio Dx Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Industry
Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines